AeroLeads people directory · profile
Jacques Galipeau Email & Phone Number
Associate Dean for Therapeutics Development
at
University of Wisconsin-Madison
1 work email found
@wisc.edu
4 phones found area 608 and 514
LinkedIn matched
✓ Verified July 2026
4 data sources
Profile completeness 100%
Current company
Role
Associate Dean for Therapeutics Development
Location
Greater Madison Area, United States
Who is Jacques Galipeau? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Jacques Galipeau is listed as Associate Dean for Therapeutics Development at University of Wisconsin-Madison, based in Greater Madison Area, United States. AeroLeads shows a work email signal at wisc.edu, phone signal with area code 608, 514, and a matched LinkedIn profile for Jacques Galipeau.
Jacques Galipeau previously worked as Assistant Dean for Therapeutics Discovery and Development at University Of Wisconsin-Madison and Director, UW Program for Advanced Cell Therapy (UW-PACT) at Uw Program For Advanced Cell Therapy. Jacques Galipeau holds Fellowship, Gene Therapy from St. Jude Children'S Research Hospital.
Company email context
Email format at University of Wisconsin-Madison
This section adds company-level context without repeating Jacques Galipeau's masked contact details.
{first_initial}{last}@wisc.edu
86% confidence
AeroLeads found 1 current-domain work email signal for Jacques Galipeau. Compare company email patterns before reaching out.
Profile bio
About Jacques Galipeau
Dr. Galipeau is an academic health center biopharmaceutical leader with broad experience leading groups responsible for discovery research, GMP compliant cell manufacture, clinical trial design, FDA regulatory approval of clinical trials within academia and execution spanning pre-clinical to first-in-human studies across multiple therapeutic areas. Specific focus on team building within university and healthcare enterprises to enable bridging to clinical development and strategic decision-making to optimize speed and impact of programs emerging from basic university research discoveries to cost effective and impactful health care living therapeutics deployment permissive for marketing approval. He is the founding director of the University of Wisconsin Program for Advanced Cell Therapy (www.pact.wisc.edu). The mission of this program is to develop personalized cell therapies for immune and malignant disorders and to promote and deploy first-in-human clinical trials of UW-Madison cell therapy innovations to improve outcomes for children and adults. He is a practicing hematologist and internationally recognized expert in discovery science and translational development of mesenchymal stromal cell therapies. Innovator in the field of engineered synthetic cytokines as novel pharmaceutical means of treating immune disorders such as colitis, multiple sclerosis and cancer.Jacques Galipeau, MD obtained his Medical Degree from the University of Montreal and completed specialty training in internal medicine at McGill University. He went on to the Tufts-affiliated New England Medical Center in Boston for three years of subspecialty training in Hematology & Medical Oncology followed by a two-year scientific fellowship in gene therapy at St-Jude Children’s research hospital in Memphis, Tennessee. Dr. Galipeau served as Hematology and Oncology Faculty at McGill University (1997-2009) and Tenured Professor and Georgia Cancer Coalition Distinguished Cancer Scholar at Emory University (2009-2016). Since 2016, he has been the Don and Marilyn Anderson Tenured Professor of Oncology within the Department of Medicine and UW Carbone Comprehensive Cancer Center at the University of Wisconsin in Madison and was appointed the inaugural Associate Dean for Therapeutics Development at the UW School of Medicine and Public Health. Dr Galipeau was President (2022-2024) of the International Society of Cell Therapy.
Listed skills include Cancer, Cell, Biotechnology, Oncology, and 14 others.
Current workplace
Jacques Galipeau's current company
Company context helps verify the profile and gives searchers a useful next step.
13 roles
Jacques Galipeau work experience
A career timeline built from the work history available for this profile.
Associate Dean For Therapeutics Development
CurrentJacques Galipeau, MD is the Associate Dean for Therapeutics Development at the School of Medicine and Public Health, effective, September 1, 2018. Dr. Galipeau was recruited to the SMPH in 2016 as Assistant Dean for Therapeutics Discovery and Development and inaugural Director of the Program for Advanced Cell Therapy (www.PACT.wisc.edu). Dr. Galipeau’s appointment as Associate Dean building on relationships he has established in his current role as Director of PACT. Dr. Galipeau will identify collaborative opportunities and assemble cross-disciplinary teams from SMPH and the entire UW campus for innovation and discovery in cell technologies and therapeutics for human clinical translation. As Associate Dean, he will also work to establish partnerships within the Wisconsin biotechnology and life sciences ecosystem ¬– involving state, federal, private, and philanthropic funding – to identify and pursue opportunities for collaboration.
Sep 2018 - Present
Assistant Dean For Therapeutics Discovery And Development
Sep 2016 - Aug 2018
Director, Uw Program For Advanced Cell Therapy (Uw-Pact)
CurrentMISSION:The mission of UW Program for Advanced Cell Therapy is to develop healthcare-friendly solutions for novel cell therapies and devices in order to improve patient outcomes.OBJECTIVES:1- To develop and deploy first-in-human UW Madison-discovered cell technologies.2- To provide access to promising collaborative cell therapy innovations that impact human health and medicine.3- To act as champions to forge productive partnerships with academic institutes and industry to improve patient outcomes.In order to meet our objective, we will enable teams of UW researchers and clinicians to transition from discovery to development and ultimately deployment of technologies and devices to clinically-relevant cell therapy products for FDA CBER IND-enabling studies of Phase I/II clinical trials.
Sep 2016 - Present
Clinical Hematologist
CurrentConsultative classic hematology clinical practice - Board Certified in Hematology by the American Board of Internal Medicine 2010-2025. Licensed to practice medicine in the State of Wisconsin.
Sep 2016 - Present
Immediate Past President & Chair, Strategic Advisory Council
Current
Jun 2024 - Present
President
As President of ISCT, I see it as my role to provide a voice to the unique challenges and opportunities that occur in the Cell & Gene Therapy field. Particularly when it comes to the role and contribution of academic health centers in first-in-human innovation and eventual end users of these technologies. ISCT has the wind in its sails. You can expect regional and international in-person meetings with an evolving focus on education and workforce training. We also hope to see continued growth and impact of our society journal: Cytotherapy. Most importantly, ISCT will continue giving a voice to the three pillars of our membership in shaping the cell therapy ecosystem for it to meet its full beneficence for improving human outcomes.
Jun 2022 - May 2024
President Elect
Established in 1992, the International Society for Cell & Gene Therapy (ISCT- https://isctglobal.org/) is a global society of clinicians, regulators, researchers, technologists and industry partners with a shared vision to translate cellular and gene therapy into safe and effective therapies to improve patients’ lives worldwide. Comprised of over 2500 cell and gene therapy experts across five geographic regions and representation from over 60 countries, ISCT members are part of a global community of peers, thought leaders and organizations invested in cell and gene therapy translation.
Jun 2020 - May 2022
Director, Emory Personalized Immunotherapy Center [Epic]
EPIC Mission Statement. We wish to render accessible to the patient community cutting edge, innovative cellular pharmaceuticals and biotherapies for treatment of human catastrophic illnesses. The clinical translation mandate is inclusive and we will promote development of technologies from Institutional scientists as well as partnership development of technologies from sister biomedical institutions, academic networks, biotechnology firms and pharmaceutical industry.
Jun 2011 - Aug 2016
Clinical Hematologist
Consultative classic hematology clinical practice - Board Certified in Hematology by the American Board of Internal Medicine 2010-2020. Licensed to practice medicine in the state of Georgia.
Jul 2010 - Aug 2016
Professor Of Hematology And Medical Oncology, Pediatrics And Medicine
Tenured Professor and senior research scientist. My laboratory research is focused on cell and biological therapy of cancer and immune ailments. We are also exploring the utility of mesenchymal stem cells and B regulatory cells for regenerative medicine, immune modulation and for delivery of therapeutic proteins for treatment of acquired and hereditary diseases.
Oct 2009 - Aug 2016
Associate Professor Of Medicine And Oncology
Tenured University Clinician Scientist and Staff Hematologist
Jun 2004 - Oct 2009
Jun 1997 - Jun 2004
4 education records
Jacques Galipeau education
Fellowship, Gene Therapy
St. Jude Children'S Research Hospital
Fellowship, Hematology & Medical Oncology
Tufts University School Of Medicine
Residency, Internal Medicine
Mcgill University
Md, Medicine
Université De Montréal
FAQ
Frequently asked questions about Jacques Galipeau
Quick answers generated from the profile data available on this page.
What company does Jacques Galipeau work for?
Jacques Galipeau works for University of Wisconsin-Madison.
What is Jacques Galipeau's role at University of Wisconsin-Madison?
Jacques Galipeau is listed as Associate Dean for Therapeutics Development at University of Wisconsin-Madison.
What is Jacques Galipeau's email address?
AeroLeads has found 1 work email signal at @wisc.edu for Jacques Galipeau at University of Wisconsin-Madison.
What is Jacques Galipeau's phone number?
AeroLeads has found 4 phone signal(s) with area code 608, 514 for Jacques Galipeau at University of Wisconsin-Madison.
Where is Jacques Galipeau based?
Jacques Galipeau is based in Greater Madison Area, United States while working with University of Wisconsin-Madison.
What companies has Jacques Galipeau worked for?
Jacques Galipeau has worked for University Of Wisconsin-Madison, Uw Program For Advanced Cell Therapy, Uw Health, Isct, International Society For Cell & Gene Therapy, and Emory University School Of Medicine.
How can I contact Jacques Galipeau?
You can use AeroLeads to view verified contact signals for Jacques Galipeau at University of Wisconsin-Madison, including work email, phone, and LinkedIn data when available.
What schools did Jacques Galipeau attend?
Jacques Galipeau holds Fellowship, Gene Therapy from St. Jude Children'S Research Hospital.
What skills is Jacques Galipeau known for?
Jacques Galipeau is listed with skills including Cancer, Cell, Biotechnology, Oncology, Clinical Trials, Clinical Research, Life Sciences, and Molecular Biology.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial